The latest new contracts, like Ailux Biologics a Division of XtalPi’s — who’s behind them and what they mean, delivered to your inbox every week. No credit card, unsubscribe anytime.
Weekly Digest
New new contracts, summarized for you
Straight to Inbox
No login, no app to check — it comes to you
Contract Trends
See who's moving and how much in your market
No credit card required Weekly contract digest
Ailux Biologics Enters into License Agreement with Janssen Biotech
Ailux Biologics, a division of XtalPi, has entered into a license agreement with Janssen Biotech, a Johnson & Johnson company. The agreement grants Janssen and its affiliates a non-exclusive license to leverage Ailux Biologics' XtalFold™ platform for the discovery and engineering of biologics.
Company Information
Company
Ailux Biologics a Division of XtalPi
Location
Cambridge, Massachusetts, United States
About
Ailux Biologics is a division of XtalPi Inc., a global leader in AI drug discovery.
Predictive Intelligence
Strategic
ML-powered predictions for Ailux Biologics a Division of XtalPi's next move
CambridgeBiotechnologyArtificial IntelligenceTherapeuticsPharmaceutical